Medical warehouse licence and GSP: staffing pharmacists and device engineers
Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
The medical warehouse appears twice in this volume: once as a licensed applicant that can act as the rights holder under Article 6(1)(a), and once as the physical node in the import and storage chain. The first role decides who holds the certificate; the second decides whether the goods can be stored. The EDE import permit service page states expressly that imports from a bonded free zone require a GSP certificate issued by EDE, while the implementation of good storage and distribution practice depends on staffing. On whether the technical responsible person may be a pharmacist or a medical device engineer, and on headcount and how qualifications are retained, the position is a practical estimate with no EDE official text behind it, and it must follow the written reply of the competent authority.
- The medical warehouse is both a licence-holding applicant category and the physical storage node of the import chain.
- A medical store licence cannot substitute for a medical warehouse licence; the two licensed activities are distinct.
- An EDE-issued GSP certificate is an express condition for imports from bonded free zones.
- Technical responsible person qualifications are a practical estimate and require written confirmation from the competent authority.
2. Legal basis
The table below gathers the provisions relevant to the medical warehouse in both of its roles, together with the GSP condition published on the EDE import permit service page.
| Regulation | Reference | Publication | Provision | Key point |
| Federal Decree-Law on the Regulation of Medical Products, Pharmacists and Pharmaceutical Establishments | Federal Decree-Law No. 38/2024 | Issued 1 October 2024, effective 2 January 2025 | Article 6(1)(a) | A medical warehouse designated by the rights holder may act as the marketing authorisation applicant |
| Federal Decree-Law on the Regulation of Medical Products, Pharmacists and Pharmaceutical Establishments | Federal Decree-Law No. 38/2024 | Issued 1 October 2024, effective 2 January 2025 | Article 21 | Rights-holder obligations, including vigilance and post-market cooperation requirements |
| Federal Decree-Law on the Regulation of Medical Products, Pharmacists and Pharmaceutical Establishments | Federal Decree-Law No. 38/2024 | Issued 1 October 2024, effective 2 January 2025 | Article 126 | Manufacturing sites must meet GMP, which interlocks with the storage stage requirements |
| EDE service page: import permit for medical items and products | Service page, no reference number | Currently published on the EDE website | Bonded free zone conditions | Imports from bonded free zones require a GSP certificate issued by EDE |
3. Expert insights
Insight 1: a medical warehouse and a medical store are not the same thing, and their licensed activities must not be mixed. The two licences are parallel and distinct licensed activities in the UAE, and a medical store has no authority to perform the storage and distribution functions of a medical warehouse. We have encountered multiple cases of rejection because the partner presented a medical store licence yet was written into the submission as the storage node. When verifying, read the licensed activity description on the face of the licence itself, rather than relying on the partner’s own account of its business capability.
Insight 2: the GSP certificate is an express official condition, and the certificate itself is not a one-off asset. The EDE service page lists the GSP certificate as one of the necessary conditions for bonded free zone imports, and requires it to be issued by EDE. In our judgement, the holder must continuously meet operational requirements concerning temperature, humidity, zoning, traceability and recall drills throughout the life of the certificate; any deviation found in a single on-site inspection can ripple into the pace at which import permits are issued. We recommend turning the GSP operating status into a monthly self-check item, rather than rushing remediation before a renewal or an inspection.
Insight 3: staffing is a practical estimate, and the competent authority must be consulted before the establishment plan is fixed. The position that the technical responsible person may be a pharmacist or a medical device engineer derives from prevailing industry practice; Article 6(1)(a) and Article 21 of Federal Decree-Law No. 38/2024 do not prescribe the qualifications for the role. Our recommendation is to front-load the confirmation: before site selection and recruitment, obtain a written reply from EDE or the competent emirate-level authority, clarifying the degree requirements, registration status and form of in-post evidence, so that the establishment plan does not have to be redone because the qualifications are later not recognised.
4. Practical recommendations
- Verify the face of the licence of the proposed warehousing partner, confirming the licensed activity is a medical warehouse and not a medical store, and retain a verification record.
- If the bonded free zone route is used, obtain the EDE-issued GSP certificate first, and check the certificate’s coverage and validity at the same time.
- Establish a monthly GSP self-check covering temperature and humidity records, zoned storage, traceability ledgers and recall drills, with executable evidence retained.
- Before site selection and recruitment, confirm in writing with the competent authority the position on technical responsible person qualifications, including degree, registration and in-post evidence requirements (practical estimate).
- Bring storage node changes under change management: a change of warehouse or responsible person should trigger re-verification of qualifications and a review of any impact on the Article 22 architecture.
- Agree with the Article 22 lead establishment on information transfer paths, so that storage anomalies, returns and recall information can be returned promptly to the rights holder.
5. Verification checklist
- □ The licensed activity on the warehousing partner’s licence has been confirmed as a medical warehouse, with no substitution by a medical store
- □ The EDE GSP certificate required for the bonded free zone route has been obtained, with coverage and validity checked
- □ Execution records for temperature and humidity, zoning, traceability ledgers and recall drills are complete and traceable month by month
- □ The technical responsible person position has been confirmed in writing by the competent authority and staffed to its requirements (practical estimate)
- □ A re-verification process exists for warehouse and responsible person changes, with the impact on the Article 22 architecture assessed
- □ The information transfer paths with the lead establishment for storage anomalies, returns and recalls are agreed in writing
- □ Warehouse inbound and outbound records are aligned with the Article 66 database registration requirement, with batches traceable in both directions
How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the United Arab Emirates. Our team coordinates local authorised representative and importer arrangements, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us